Analyst on Coloplast: Very good financial report was helped by favorable currency rates
Medtech company Coloplast lifted its organic growth over the market’s estimates in Q1, and the company could also add a little to the top line due to positive currency fluctuations. All in all, Coloplast’s report is very good, says Analyst Søren Løntoft Hansen.
by marketwire, translated by daniel pedersen
Positive currency fluctuations – driven by a strong American dollar – have helped lift the medtech company’s top line in the first quarter of financial 2021/2022, where the company’s revenue beat expectations.